Improving diet quality for people with high blood pressure using a mobile app
The Effect of Goal Setting With Mobile-based Self-management Tool on Improving Diet Quality of People With High Blood Pressure: a Randomized Controlled Trial
This study tests if using a mobile app to set diet goals and track eating habits can help people with high blood pressure improve their diet and manage their condition better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 110 (estimated) |
| Ages | 20 Years to 70 Years |
| Sex | All |
| Sponsor | China National Center for Cardiovascular Diseases Government |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06988501 on ClinicalTrials.gov |
What this trial studies
This study explores the use of SMART goal setting combined with a mobile-based self-management tool to enhance dietary habits in individuals with high blood pressure. Participants will engage in goal setting and receive nutrition education through a smartphone application designed to track their diet and provide feedback. The aim is to improve diet quality and encourage behavioral changes that can lead to better management of hypertension. The intervention targets individuals who are motivated to improve their eating habits and can effectively use mobile technology.
Who should consider this trial
Good fit: Ideal candidates are adults aged 20-70 with a diagnosis of hypertension and an unhealthy diet.
Not a fit: Patients with severe cardiovascular or respiratory diseases, uncontrolled blood pressure, or diagnosed mental illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved dietary habits and better blood pressure management for patients.
How similar studies have performed: Other studies have shown promise in using mobile applications for health management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 20-70; * Hypertension diagnosis, or high blood pressure (SBP between 120-139 mmHg and/or DBP between 80-89 mmHg); * Eating an unhealthy diet (estimated DASH score \< 6) ; * Owning a smartphone and able to operate it proficiently; * Sign the informed consent. Exclusion Criteria: * Severe cardiovascular and respiratory diseases, such as acute myocardial infarction, tachyarrhythmia, pulmonary edema, and severe aortic stenosis; * Acute phase of cardiovascular and cerebrovascular diseases; * Uncontrolled blood pressure; * Diagnosed mental diseases or epilepsy; * Cardiac pacemaker implantation; * Allergic constitutions; * Pregnant women or planning to become pregnant; * Individuals who have participated in other clinical studies within the past 3 months; * Refuse to sign the informed consent.
Where this trial is running
Beijing, Beijing Municipality
- Fuwai Hospital, National Center for Cardiovascular Diseases — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Xuezhu Sun
- Email: hlm2020fw@163.com
- Phone: +86 10 88396188
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.